Mexico’s Cofepris has granted marketing authorization for lenacapavir as twice-yearly injectable pre-exposure prophylaxis against HIV, placing Mexico among a small group of countries with regulatory access to the long-acting prevention …
Mexico’s Cofepris has granted marketing authorization for lenacapavir as twice-yearly injectable pre-exposure prophylaxis against HIV, placing Mexico among a small group of countries with regulatory access to the long-acting prevention …
Donanemab is now infused in a Mexican public hospital. Lilly’s 2026 target: 30 patients — the gap between innovation and the system, in one number.
Ecuador’s government is in talks with Colombia, India, Argentina, and Costa Rica to procure medicines for public hospitals, as shortages and a trade dispute with Colombia strain the health system.
Uruguay’s Ministry of Public Health and mutual insurers have agreed to incorporate 12 high-cost medicines into the national formulary, reducing per-unit acquisition costs from up to 100,000 pesos to approximately …
Ecuador’s Sercop signed 114 medication supply agreements in May–June 2026, but 71 carry no purchase orders as of mid-August — leaving contracted suppliers unpaid and public hospital shelves empty.
You must be logged in to post a comment.